Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.

Hirt D, Mentré F, Tran A, Rey E, Auleley S, Salmon D, Duval X, Tréluyer JM, COPHAR2- ANRS Study Group

Open source

DOI
10.1111/j.1365-2125.2007.03039.x
Published
2008 Apr
Container
British journal of clinical pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/j.1365-2125.2007.03039.x,
  title = {Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.},
  author = {Hirt D and Mentré F and Tran A and Rey E and Auleley S and Salmon D and Duval X and Tréluyer JM and COPHAR2- ANRS Study Group},
  year = {2008},
  journal = {British journal of clinical pharmacology},
  doi = {10.1111/j.1365-2125.2007.03039.x},
  url = {https://doi.org/10.1111/j.1365-2125.2007.03039.x}
}

RIS

TY  - JOUR
TI  - Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
AU  - Hirt D
AU  - Mentré F
AU  - Tran A
AU  - Rey E
AU  - Auleley S
AU  - Salmon D
AU  - Duval X
AU  - Tréluyer JM
AU  - COPHAR2- ANRS Study Group
PY  - 2008
JO  - British journal of clinical pharmacology
DO  - 10.1111/j.1365-2125.2007.03039.x
UR  - https://doi.org/10.1111/j.1365-2125.2007.03039.x
ER  - 

APA

D, H., F, M., A, T., E, R., S, A., D, S., X, D., JM, T., & Group, C. A. S. (2008). Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.. British journal of clinical pharmacology. https://doi.org/10.1111/j.1365-2125.2007.03039.x

Source records